Factors for Overall Survival in Patients with Skull Base Chordoma: A Retrospective Analysis of 225 Patients

被引:16
|
作者
Tian, Kaibing [1 ]
Zhang, Haoyu [1 ]
Ma, Junpeng [1 ]
Wang, Ke [1 ]
Ru, Xiaojuan [2 ]
Du, Jiang [3 ]
Jia, Guijun [1 ]
Zhang, Liwei [1 ]
Wu, Zhen [1 ]
Zhang, Junting [1 ]
Wang, Liang [1 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuroepidemiol, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuropathol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Chordoma; Overall survival; Prognostic factor; Skull base; Surgery; CRANIOCERVICAL JUNCTION; INTRACRANIAL CHORDOMAS; CLINICAL ARTICLE; TUMOR RECURRENCE; MANAGEMENT; OUTCOMES; PREDICTORS; FEATURES; DISEASE; AGE;
D O I
10.1016/j.wneu.2016.09.055
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Although a controversial and complex issue, the prognostic factors of skull base chordomas are worth exploring. METHODS: Prognostic factors associated with overall survival (OS) were retrospectively estimated in an individual cohort of skull base chordomas prospectively maintained for 10 years by a Kaplan-Meier method and univariate Cox proportional hazards model. Multivariate analysis by Cox regression analysis was performed to identify the independent prognostic factors. A nomogram was then formulated by R software based on the results. RESULTS: A total of 180 primary patients and 45 recurrent cases were included, with a mean follow-up period of 43.7 months (range, 4-127 months). The OS of the primary group at 5 years and 7 years was 84% and 78%, and the mean OS was 103.8 months, which was significantly longer than the recurrent group, in which the mean postrecurrent OS was 68.4 months. In the primary group, preoperative Karnofsky Performance Status (KPS) score (P = 0.004) and a decline of perioperative KPS score (P = 0.015) were identified as independent predictors of OS. A nomogram was contracted to predict 5-year, and 7-year OS, which was well calibrated and had good discriminative ability (adjusted Harrell C statistic, 0.74). In the recurrent group, visual deficit was verified as an independent risk factor associated with postrecurrent OS (P = 0.014). CONCLUSIONS: Both pathologic and perioperative KPS score evaluations are significant in OS prediction of both primary and recurrent cases. The nomogram for primary lesions, consisting of preoperative functional status and its perioperative changes, appears useful for risk stratification of long-term survival.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 50 条
  • [21] Novel Nomograms as Aids for Predicting Recurrence and Survival in Chordoma Patients A Retrospective Multicenter Study in mainland China
    Meng, Tong
    Huang, Runzhi
    Hu, Peng
    Yin, Huabin
    Lin, Shaojian
    Qiao, Suchi
    Wang, Renkai
    Wang, Jing
    Cai, Zhengdong
    Huang, Zongqiang
    Cheng, Liming
    Song, Dianwen
    SPINE, 2021, 46 (01) : E37 - E47
  • [22] High Dose Radiosurgery Targeting the Primary Tumor Sites Contributes to Survival in Patients With Skull Base Chordoma
    Shinya, Yuki
    Hasegawa, Hirotaka
    Shin, Masahiro
    Kawashima, Mariko
    Koga, Tomoyuki
    Hanakita, Shunya
    Katano, Atsuto
    Sugiyama, Takehiro
    Nozawa, Yuki
    Saito, Nobuhito
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (03): : 582 - 587
  • [23] Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma
    Jacob L. Freeman
    Franco DeMonte
    Wajd Al-Holou
    Paul W. Gidley
    Ehab Y. Hanna
    Michael E. Kupferman
    Shirley Y. Su
    Shaan M. Raza
    Acta Neurochirurgica, 2018, 160 : 731 - 740
  • [24] Assessing survival outcomes and complication profiles following surgical excision and radiotherapy as interventions for skull base chordoma: a systematic review of operative margins and surgical approaches
    Brown, Nolan J.
    Gendreau, Julian
    Kuo, Cathleen C.
    Nguyen, Oanh
    Yang, Chenyi
    Catapano, Joshua S.
    Lawton, Michael T.
    JOURNAL OF NEURO-ONCOLOGY, 2023, 165 (1) : 41 - 51
  • [25] Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival
    Bakker, S. H.
    Jacobs, W. C. H.
    Pondaag, W.
    Gelderblom, H.
    Nout, R. A.
    Dijkstra, P. D. S.
    Peul, W. C.
    Vleggeert-Lankamp, C. L. A.
    EUROPEAN SPINE JOURNAL, 2018, 27 (12) : 3043 - 3058
  • [26] Surgical outcomes and risk factors for overall mortality in brain arteriovenous malformations patients: a retrospective analysis
    Miron, Ioana
    Pruna, Viorel M.
    Visarion, Dan M.
    Petrescu, George E. D.
    Gorgan, Radu M.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [27] Chordoma of the Skull Base: A National Cancer Database Analysis of Current Practice Patterns and Outcomes
    Nunna, Ravi
    Patel, Saavan
    Karuparti, Sasi
    Ortiz-Torres, Michael
    Ryoo, James
    Ansari, Darius
    Carr, Steven
    Mehta, Ankit I.
    WORLD NEUROSURGERY, 2022, 168 : E260 - E268
  • [28] Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience
    Tubin, Slavisa
    Fossati, Piero
    Mock, Ulrike
    Luetgendorf-Caucig, Carola
    Flechl, Birgit
    Pelak, Maciej
    Georg, Petra
    Fussl, Christoph
    Carlino, Antonio
    Stock, Markus
    Hug, Eugen
    CANCERS, 2023, 15 (07)
  • [29] Analysis of Clinical Features and Outcomes of Skull Base Chordoma in Different Age-Groups
    Tian, Kaibing
    Wang, Liang
    Wang, Ke
    Ma, Junpeng
    Li, Da
    Hao, Shuyu
    Yang, Yang
    Du, Jiang
    Jia, Guijun
    Zhang, Liwei
    Wu, Zhen
    Zhang, Junting
    WORLD NEUROSURGERY, 2016, 92 : 407 - 417
  • [30] Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review
    Wallace, Gerald
    Kundalia, Ronak
    Vallebuona, Ethan
    Cao, Biwei
    Kim, Youngchul
    Forsyth, Peter
    Soyano, Aixa
    Smalley, Inna
    Pina, Yolanda
    BREAST CANCER RESEARCH, 2024, 26 (01)